Synthesis of positive plasmas with known chromosomal abnormalities for validation of non-invasive prenatal screening
暂无分享,去创建一个
[1] M. Norton. Circulating Cell-free DNA and Screening for Trisomies. , 2022, The New England journal of medicine.
[2] J. Waldron,et al. Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. , 2020, Cell reports.
[3] L. Vallier,et al. Chapter 9 Cell Culture Growing Cells as Model Systems In Vitro , 2017, Basic Science Methods for Clinical Researchers.
[4] D. Muzzey,et al. Noninvasive Prenatal Screening at Low Fetal Fraction: Comparing Whole-Genome Sequencing and Single-Nucleotide Polymorphism Methods , 2016, bioRxiv.
[5] C. Raymond,et al. Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory setting , 2017, PloS one.
[6] P. Jiang,et al. The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics. , 2016, Trends in genetics : TIG.
[7] John Tynan,et al. Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts , 2015, Prenatal diagnosis.
[8] Diana Miglioretti,et al. Cell-free DNA Analysis for Noninvasive Examination of Trisomy. , 2015, The New England journal of medicine.
[9] J. Canick,et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies , 2013, Prenatal diagnosis.
[10] Stephen R. Quake,et al. Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics , 2010, PloS one.
[11] C. Cantor,et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.
[12] I. Sargent,et al. Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.